Gene Symbol | Gene ID | Gene Info |
---|---|---|
Prrx1
|
ENSMUSG00000026586.10 | paired related homeobox 1 |
Isx
|
ENSMUSG00000031621.3 | intestine specific homeobox |
Prrxl1
|
ENSMUSG00000041730.7 | paired related homeobox protein-like 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_74930880_74931043 | Isx | 57421 | 0.106624 | 0.74 | 9.3e-02 | Click! |
chr1_163338521_163338892 | Prrx1 | 24996 | 0.155250 | 0.65 | 1.6e-01 | Click! |
chr1_163339232_163339434 | Prrx1 | 25623 | 0.154031 | 0.59 | 2.2e-01 | Click! |
chr1_163314475_163314642 | Prrx1 | 848 | 0.594097 | 0.56 | 2.5e-01 | Click! |
chr1_163339006_163339167 | Prrx1 | 25376 | 0.154513 | 0.38 | 4.6e-01 | Click! |
chr1_163314220_163314397 | Prrx1 | 598 | 0.725915 | 0.16 | 7.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_74672657_74672818 | 1.21 |
Gm27233 |
predicted gene 27233 |
36525 |
0.18 |
chr17_79018863_79019084 | 0.92 |
Prkd3 |
protein kinase D3 |
1804 |
0.3 |
chr9_74885383_74885534 | 0.85 |
Onecut1 |
one cut domain, family member 1 |
18974 |
0.14 |
chr11_16798476_16798627 | 0.72 |
Egfros |
epidermal growth factor receptor, opposite strand |
32151 |
0.16 |
chr3_76637152_76637321 | 0.71 |
Fstl5 |
follistatin-like 5 |
43686 |
0.19 |
chr9_74881714_74881880 | 0.68 |
Onecut1 |
one cut domain, family member 1 |
15313 |
0.15 |
chr5_86919547_86919811 | 0.64 |
Gm25211 |
predicted gene, 25211 |
3357 |
0.13 |
chr10_124590350_124590536 | 0.60 |
4930503E24Rik |
RIKEN cDNA 4930503E24 gene |
67005 |
0.14 |
chr10_87936931_87937082 | 0.60 |
Tyms-ps |
thymidylate synthase, pseudogene |
29841 |
0.15 |
chr15_58983651_58983950 | 0.60 |
4930544F09Rik |
RIKEN cDNA 4930544F09 gene |
336 |
0.87 |
chr16_43169836_43170008 | 0.58 |
Gm15712 |
predicted gene 15712 |
14651 |
0.21 |
chr1_100298746_100298897 | 0.55 |
Gm29667 |
predicted gene 29667 |
16030 |
0.18 |
chr5_33465811_33466048 | 0.53 |
Gm43851 |
predicted gene 43851 |
28465 |
0.15 |
chr11_16888258_16888409 | 0.52 |
Egfr |
epidermal growth factor receptor |
10183 |
0.2 |
chr11_16843001_16843162 | 0.51 |
Egfros |
epidermal growth factor receptor, opposite strand |
12379 |
0.2 |
chr12_51274477_51274668 | 0.51 |
Rps11-ps4 |
ribosomal protein S11, pseudogene 4 |
22915 |
0.22 |
chr17_81174915_81175073 | 0.50 |
Gm50042 |
predicted gene, 50042 |
71744 |
0.11 |
chr1_124069161_124069328 | 0.50 |
Dpp10 |
dipeptidylpeptidase 10 |
23685 |
0.27 |
chr16_4384061_4384228 | 0.50 |
Adcy9 |
adenylate cyclase 9 |
35443 |
0.15 |
chr13_115653702_115653853 | 0.49 |
Gm47892 |
predicted gene, 47892 |
65722 |
0.13 |
chr6_55171107_55171477 | 0.48 |
Inmt |
indolethylamine N-methyltransferase |
3722 |
0.2 |
chr10_87868820_87868971 | 0.48 |
Igf1os |
insulin-like growth factor 1, opposite strand |
5514 |
0.22 |
chr8_38604147_38604298 | 0.47 |
Gm40493 |
predicted gene, 40493 |
55541 |
0.14 |
chr13_24360335_24360523 | 0.46 |
Gm11342 |
predicted gene 11342 |
15521 |
0.12 |
chr11_16883025_16883203 | 0.46 |
Egfr |
epidermal growth factor receptor |
4964 |
0.23 |
chr15_3721208_3721477 | 0.45 |
Gm4823 |
predicted gene 4823 |
25533 |
0.23 |
chr13_28877494_28877645 | 0.44 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
5887 |
0.2 |
chr5_99976807_99976958 | 0.44 |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
331 |
0.73 |
chr4_138200371_138200549 | 0.43 |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
1129 |
0.38 |
chr11_16761103_16761540 | 0.43 |
Egfr |
epidermal growth factor receptor |
9091 |
0.2 |
chr2_64059065_64059258 | 0.42 |
Fign |
fidgetin |
38827 |
0.23 |
chr10_4617695_4617851 | 0.42 |
Esr1 |
estrogen receptor 1 (alpha) |
5752 |
0.25 |
chr16_43234125_43234650 | 0.42 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1493 |
0.45 |
chr19_37507552_37507703 | 0.41 |
Exoc6 |
exocyst complex component 6 |
13252 |
0.16 |
chr8_76152735_76152886 | 0.41 |
Gm45742 |
predicted gene 45742 |
35783 |
0.19 |
chr1_67150788_67150939 | 0.40 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
27837 |
0.2 |
chr5_96970232_96970383 | 0.40 |
Gm9484 |
predicted gene 9484 |
27057 |
0.09 |
chr4_90082681_90082858 | 0.40 |
Gm12629 |
predicted gene 12629 |
102758 |
0.08 |
chr1_140421414_140421565 | 0.39 |
Kcnt2 |
potassium channel, subfamily T, member 2 |
21447 |
0.27 |
chr18_53860444_53860644 | 0.39 |
Csnk1g3 |
casein kinase 1, gamma 3 |
1578 |
0.52 |
chr11_80103009_80103182 | 0.39 |
Atad5 |
ATPase family, AAA domain containing 5 |
92 |
0.96 |
chr6_100267052_100267222 | 0.38 |
Gm44044 |
predicted gene, 44044 |
6561 |
0.17 |
chr3_133759501_133760150 | 0.38 |
Gm6135 |
prediticted gene 6135 |
31679 |
0.18 |
chr1_9985468_9985649 | 0.37 |
Ppp1r42 |
protein phosphatase 1, regulatory subunit 42 |
134 |
0.92 |
chr19_40153747_40153898 | 0.37 |
Cyp2c70 |
cytochrome P450, family 2, subfamily c, polypeptide 70 |
33464 |
0.13 |
chrX_61144273_61144442 | 0.37 |
Gm24396 |
predicted gene, 24396 |
1005 |
0.5 |
chr10_19452656_19452840 | 0.36 |
Gm33104 |
predicted gene, 33104 |
33967 |
0.17 |
chr5_125526040_125526191 | 0.36 |
Tmem132b |
transmembrane protein 132B |
5659 |
0.17 |
chr1_162891903_162892071 | 0.36 |
Fmo2 |
flavin containing monooxygenase 2 |
5472 |
0.19 |
chr19_27663441_27663619 | 0.34 |
Gm24782 |
predicted gene, 24782 |
40477 |
0.2 |
chr11_16885540_16885691 | 0.34 |
Egfr |
epidermal growth factor receptor |
7465 |
0.21 |
chr9_31589555_31589723 | 0.34 |
Gm18226 |
predicted gene, 18226 |
21393 |
0.16 |
chr13_44437957_44438156 | 0.34 |
1700029N11Rik |
RIKEN cDNA 1700029N11 gene |
1656 |
0.27 |
chr16_26702287_26702472 | 0.34 |
Il1rap |
interleukin 1 receptor accessory protein |
20055 |
0.24 |
chr15_38049613_38049764 | 0.33 |
Gm22353 |
predicted gene, 22353 |
8597 |
0.16 |
chr15_3475054_3475205 | 0.33 |
Ghr |
growth hormone receptor |
3485 |
0.35 |
chr3_142458835_142459002 | 0.33 |
Gbp5 |
guanylate binding protein 5 |
35060 |
0.15 |
chr6_108667181_108667428 | 0.32 |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
4258 |
0.19 |
chr3_18137155_18137306 | 0.32 |
Gm23686 |
predicted gene, 23686 |
40395 |
0.15 |
chr2_84996201_84996436 | 0.32 |
Prg3 |
proteoglycan 3 |
8103 |
0.12 |
chr1_140415315_140415670 | 0.32 |
Kcnt2 |
potassium channel, subfamily T, member 2 |
27444 |
0.25 |
chr6_71999696_71999905 | 0.32 |
Gm26628 |
predicted gene, 26628 |
36025 |
0.1 |
chr5_92607049_92607221 | 0.32 |
Stbd1 |
starch binding domain 1 |
4067 |
0.19 |
chr4_118002076_118002227 | 0.31 |
9530034E10Rik |
RIKEN cDNA 9530034E10 gene |
27115 |
0.13 |
chr2_77543027_77543190 | 0.31 |
Zfp385b |
zinc finger protein 385B |
18872 |
0.25 |
chr3_95879412_95879563 | 0.31 |
Ciart |
circadian associated repressor of transcription |
1759 |
0.16 |
chr6_90434918_90435091 | 0.31 |
Cfap100 |
cilia and flagella associated protein 100 |
6207 |
0.12 |
chr15_38105734_38106027 | 0.31 |
Gm49312 |
predicted gene, 49312 |
26778 |
0.13 |
chr2_58773576_58773851 | 0.30 |
Upp2 |
uridine phosphorylase 2 |
8388 |
0.21 |
chrX_109145684_109145835 | 0.30 |
Gm14869 |
predicted gene 14869 |
24075 |
0.17 |
chr11_16854059_16854210 | 0.30 |
Egfros |
epidermal growth factor receptor, opposite strand |
23432 |
0.17 |
chr10_69208679_69208830 | 0.30 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
202 |
0.94 |
chr2_134708873_134709037 | 0.30 |
Gm14037 |
predicted gene 14037 |
22152 |
0.2 |
chr2_121507198_121507349 | 0.30 |
Wdr76 |
WD repeat domain 76 |
490 |
0.46 |
chr3_18246603_18246795 | 0.30 |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
3361 |
0.3 |
chr19_39282868_39283045 | 0.30 |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
4118 |
0.26 |
chr12_75483854_75484042 | 0.29 |
Gm47690 |
predicted gene, 47690 |
24797 |
0.19 |
chr4_122977007_122977265 | 0.29 |
4933421A08Rik |
RIKEN cDNA 4933421A08 gene |
15827 |
0.12 |
chr10_68125559_68125710 | 0.29 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
10992 |
0.25 |
chr18_36641373_36641566 | 0.29 |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
96 |
0.93 |
chr19_29120309_29120493 | 0.29 |
Mir101b |
microRNA 101b |
14878 |
0.12 |
chr4_99068687_99068838 | 0.29 |
Dock7 |
dedicator of cytokinesis 7 |
1651 |
0.35 |
chr5_135036438_135036589 | 0.29 |
Stx1a |
syntaxin 1A (brain) |
998 |
0.3 |
chr3_98670706_98671055 | 0.29 |
Gm12399 |
predicted gene 12399 |
7451 |
0.14 |
chr4_49691674_49691844 | 0.28 |
Ppp3r2 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) |
9735 |
0.18 |
chr6_128035036_128035224 | 0.28 |
Tspan9 |
tetraspanin 9 |
125 |
0.96 |
chr8_80983213_80983373 | 0.28 |
Gm9725 |
predicted gene 9725 |
30283 |
0.13 |
chr14_17729212_17729405 | 0.28 |
Gm48320 |
predicted gene, 48320 |
41814 |
0.19 |
chr10_87040962_87041138 | 0.28 |
1700113H08Rik |
RIKEN cDNA 1700113H08 gene |
16995 |
0.16 |
chr1_60098880_60099160 | 0.28 |
Wdr12 |
WD repeat domain 12 |
375 |
0.68 |
chr12_99371949_99372100 | 0.28 |
Gm47138 |
predicted gene, 47138 |
2111 |
0.22 |
chr14_101841283_101841436 | 0.28 |
Lmo7 |
LIM domain only 7 |
540 |
0.85 |
chr5_81427449_81427610 | 0.28 |
Gm43084 |
predicted gene 43084 |
108197 |
0.07 |
chr9_106245058_106245282 | 0.27 |
Alas1 |
aminolevulinic acid synthase 1 |
1536 |
0.23 |
chr17_40896986_40897147 | 0.27 |
9130008F23Rik |
RIKEN cDNA 9130008F23 gene |
16507 |
0.11 |
chr9_122848915_122849207 | 0.27 |
Gm47140 |
predicted gene, 47140 |
643 |
0.55 |
chr11_95462552_95462764 | 0.27 |
Gm11522 |
predicted gene 11522 |
63 |
0.97 |
chr1_67222842_67222998 | 0.27 |
Gm15668 |
predicted gene 15668 |
26280 |
0.19 |
chr10_53989527_53989678 | 0.27 |
Man1a |
mannosidase 1, alpha |
12487 |
0.24 |
chr10_117123042_117123236 | 0.27 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
7707 |
0.15 |
chr12_80323831_80324032 | 0.26 |
Dcaf5 |
DDB1 and CUL4 associated factor 5 |
52761 |
0.08 |
chrX_51399106_51399311 | 0.26 |
Gm14621 |
predicted gene 14621 |
159676 |
0.03 |
chr16_52417351_52417533 | 0.26 |
Alcam |
activated leukocyte cell adhesion molecule |
35023 |
0.23 |
chr3_60099135_60099299 | 0.26 |
Sucnr1 |
succinate receptor 1 |
17315 |
0.18 |
chr12_57537784_57538085 | 0.26 |
Foxa1 |
forkhead box A1 |
8187 |
0.15 |
chr3_145775927_145776137 | 0.26 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
15284 |
0.2 |
chr16_77405236_77405411 | 0.26 |
Gm21816 |
predicted gene, 21816 |
4476 |
0.13 |
chr18_12696242_12696420 | 0.26 |
Ttc39c |
tetratricopeptide repeat domain 39C |
6603 |
0.15 |
chr5_30185873_30186127 | 0.26 |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
5768 |
0.13 |
chr8_105095555_105095947 | 0.26 |
Ces3b |
carboxylesterase 3B |
7132 |
0.11 |
chr3_133725023_133725174 | 0.26 |
Gm40153 |
predicted gene, 40153 |
61707 |
0.1 |
chr7_73542824_73542975 | 0.26 |
Chd2 |
chromodomain helicase DNA binding protein 2 |
1069 |
0.35 |
chr1_45922514_45922876 | 0.26 |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
614 |
0.65 |
chr1_155035905_155036069 | 0.25 |
Gm29441 |
predicted gene 29441 |
4248 |
0.21 |
chr13_69640079_69640317 | 0.25 |
Nsun2 |
NOL1/NOP2/Sun domain family member 2 |
9458 |
0.1 |
chr11_16814706_16815122 | 0.25 |
Egfros |
epidermal growth factor receptor, opposite strand |
15788 |
0.21 |
chr4_129325663_129325914 | 0.25 |
Rbbp4 |
retinoblastoma binding protein 4, chromatin remodeling factor |
8856 |
0.11 |
chr2_73628966_73629117 | 0.25 |
Chn1 |
chimerin 1 |
3301 |
0.21 |
chr1_185269383_185269539 | 0.25 |
Rab3gap2 |
RAB3 GTPase activating protein subunit 2 |
5619 |
0.11 |
chrX_49489499_49489695 | 0.25 |
Arhgap36 |
Rho GTPase activating protein 36 |
3922 |
0.27 |
chr2_127608341_127608498 | 0.25 |
Mrps5 |
mitochondrial ribosomal protein S5 |
8386 |
0.13 |
chr8_114140204_114140427 | 0.25 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
6673 |
0.29 |
chr10_20220217_20220400 | 0.25 |
Map7 |
microtubule-associated protein 7 |
9487 |
0.14 |
chr9_106264996_106265377 | 0.25 |
Poc1a |
POC1 centriolar protein A |
15875 |
0.1 |
chr10_93188131_93188368 | 0.25 |
Cdk17 |
cyclin-dependent kinase 17 |
6639 |
0.21 |
chr1_160968204_160968356 | 0.24 |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
10305 |
0.07 |
chr4_108099165_108099370 | 0.24 |
Podn |
podocan |
2822 |
0.2 |
chr2_134654955_134655162 | 0.24 |
Tmx4 |
thioredoxin-related transmembrane protein 4 |
10913 |
0.25 |
chr6_91583609_91583760 | 0.24 |
Gm45215 |
predicted gene 45215 |
11074 |
0.14 |
chr12_54960526_54960699 | 0.24 |
Gm27014 |
predicted gene, 27014 |
2452 |
0.2 |
chr3_75530671_75531016 | 0.24 |
Pdcd10 |
programmed cell death 10 |
9273 |
0.2 |
chr18_7657901_7658087 | 0.24 |
Mpp7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
31128 |
0.17 |
chr2_18435403_18435565 | 0.24 |
Dnajc1 |
DnaJ heat shock protein family (Hsp40) member C1 |
42654 |
0.16 |
chr4_108060521_108060686 | 0.24 |
Scp2 |
sterol carrier protein 2, liver |
10760 |
0.13 |
chr4_129326695_129326846 | 0.24 |
Rbbp4 |
retinoblastoma binding protein 4, chromatin remodeling factor |
7874 |
0.12 |
chr18_75384388_75384763 | 0.24 |
Smad7 |
SMAD family member 7 |
9661 |
0.21 |
chr18_75498893_75499229 | 0.24 |
Gm10532 |
predicted gene 10532 |
15584 |
0.25 |
chr15_59002495_59002896 | 0.24 |
4930544F09Rik |
RIKEN cDNA 4930544F09 gene |
18559 |
0.16 |
chr1_21250942_21251436 | 0.24 |
Gsta3 |
glutathione S-transferase, alpha 3 |
2332 |
0.18 |
chr14_34332268_34332419 | 0.24 |
Glud1 |
glutamate dehydrogenase 1 |
144 |
0.92 |
chr4_40698726_40698877 | 0.23 |
Aptx |
aprataxin |
3915 |
0.15 |
chr7_71419354_71419520 | 0.23 |
Gm29328 |
predicted gene 29328 |
49104 |
0.14 |
chr16_45962997_45963191 | 0.23 |
Phldb2 |
pleckstrin homology like domain, family B, member 2 |
9496 |
0.16 |
chr4_148615928_148616079 | 0.23 |
Tardbp |
TAR DNA binding protein |
135 |
0.93 |
chr5_107123329_107123511 | 0.23 |
Tgfbr3 |
transforming growth factor, beta receptor III |
9503 |
0.17 |
chr10_125785978_125786129 | 0.23 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
180115 |
0.03 |
chr13_112500544_112500748 | 0.23 |
Il6st |
interleukin 6 signal transducer |
25600 |
0.14 |
chr17_80022007_80022158 | 0.23 |
Gm22215 |
predicted gene, 22215 |
11432 |
0.14 |
chr9_23436438_23436789 | 0.23 |
Bmper |
BMP-binding endothelial regulator |
62681 |
0.16 |
chr8_109981175_109981347 | 0.23 |
Gm45795 |
predicted gene 45795 |
6909 |
0.13 |
chr13_20406351_20406565 | 0.23 |
Elmo1 |
engulfment and cell motility 1 |
66268 |
0.1 |
chr5_130227356_130227532 | 0.23 |
Gm42467 |
predicted gene 42467 |
1228 |
0.28 |
chr2_67898259_67898744 | 0.22 |
Gm37964 |
predicted gene, 37964 |
95 |
0.98 |
chr15_3500848_3501048 | 0.22 |
Ghr |
growth hormone receptor |
29304 |
0.23 |
chr13_62872928_62873142 | 0.22 |
Fbp1 |
fructose bisphosphatase 1 |
277 |
0.87 |
chr4_121078016_121078199 | 0.22 |
Zmpste24 |
zinc metallopeptidase, STE24 |
369 |
0.74 |
chr3_117078471_117078622 | 0.22 |
1700061I17Rik |
RIKEN cDNA 1700061I17 gene |
781 |
0.64 |
chr7_67658992_67659201 | 0.22 |
Ttc23 |
tetratricopeptide repeat domain 23 |
3649 |
0.17 |
chr17_15827084_15827313 | 0.22 |
Rgmb |
repulsive guidance molecule family member B |
612 |
0.68 |
chr9_64594586_64594757 | 0.22 |
Megf11 |
multiple EGF-like-domains 11 |
47772 |
0.15 |
chr9_109966945_109967106 | 0.22 |
Map4 |
microtubule-associated protein 4 |
1992 |
0.21 |
chr10_121349776_121349943 | 0.22 |
Gm48435 |
predicted gene, 48435 |
601 |
0.58 |
chr15_55043394_55043818 | 0.22 |
Taf2 |
TATA-box binding protein associated factor 2 |
2560 |
0.24 |
chr1_163817675_163817827 | 0.22 |
Kifap3 |
kinesin-associated protein 3 |
38168 |
0.16 |
chr6_24610042_24610446 | 0.22 |
Lmod2 |
leiomodin 2 (cardiac) |
12482 |
0.14 |
chr19_39287276_39287531 | 0.22 |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
329 |
0.91 |
chr2_146546861_146547083 | 0.22 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
4041 |
0.3 |
chr11_38774641_38774792 | 0.22 |
Gm23520 |
predicted gene, 23520 |
23561 |
0.29 |
chr1_172700535_172700739 | 0.22 |
Crp |
C-reactive protein, pentraxin-related |
2581 |
0.25 |
chr11_16834846_16835011 | 0.22 |
Egfros |
epidermal growth factor receptor, opposite strand |
4226 |
0.25 |
chr2_142767278_142767429 | 0.22 |
Gm22310 |
predicted gene, 22310 |
19543 |
0.24 |
chr7_97411671_97412103 | 0.22 |
Thrsp |
thyroid hormone responsive |
5632 |
0.13 |
chr13_24807889_24808047 | 0.22 |
Gm22358 |
predicted gene, 22358 |
3600 |
0.15 |
chr9_71176619_71176770 | 0.22 |
Gm32511 |
predicted gene, 32511 |
7918 |
0.18 |
chr11_120238015_120238347 | 0.21 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
1482 |
0.22 |
chr1_166738122_166738280 | 0.21 |
Gm4954 |
predicted gene 4954 |
23944 |
0.18 |
chr2_65212598_65212873 | 0.21 |
Cobll1 |
Cobl-like 1 |
23260 |
0.17 |
chr10_89635999_89636292 | 0.21 |
Slc17a8 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
14892 |
0.17 |
chr2_154827673_154827835 | 0.21 |
Raly |
hnRNP-associated with lethal yellow |
36039 |
0.12 |
chr9_78290015_78290178 | 0.21 |
Gm10639 |
predicted gene 10639 |
168 |
0.9 |
chr19_7790468_7790619 | 0.21 |
Slc22a26 |
solute carrier family 22 (organic cation transporter), member 26 |
12035 |
0.17 |
chr8_94394237_94394701 | 0.21 |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
938 |
0.39 |
chr19_10087853_10088030 | 0.21 |
Fads2 |
fatty acid desaturase 2 |
775 |
0.57 |
chr13_9097229_9097400 | 0.21 |
Larp4b |
La ribonucleoprotein domain family, member 4B |
3332 |
0.2 |
chr13_37278588_37278758 | 0.21 |
Gm47709 |
predicted gene, 47709 |
30013 |
0.13 |
chr6_51695515_51695666 | 0.21 |
Gm38811 |
predicted gene, 38811 |
15491 |
0.23 |
chr16_79086922_79087073 | 0.21 |
Tmprss15 |
transmembrane protease, serine 15 |
4095 |
0.35 |
chrX_77473868_77474135 | 0.21 |
Gm5937 |
predicted gene 5937 |
17415 |
0.21 |
chr7_119978745_119978903 | 0.21 |
Gm25217 |
predicted gene, 25217 |
9003 |
0.16 |
chr8_93245968_93246147 | 0.21 |
Gm45727 |
predicted gene 45727 |
5118 |
0.15 |
chr2_17326719_17326870 | 0.21 |
Nebl |
nebulette |
34292 |
0.22 |
chr5_150270318_150270506 | 0.21 |
Fry |
FRY microtubule binding protein |
10645 |
0.18 |
chr6_144895356_144895507 | 0.21 |
Gm22792 |
predicted gene, 22792 |
91799 |
0.07 |
chr6_51586079_51586243 | 0.21 |
Gm22914 |
predicted gene, 22914 |
35471 |
0.16 |
chr4_134814659_134814853 | 0.20 |
Maco1 |
macoilin 1 |
3543 |
0.24 |
chr2_75669473_75669624 | 0.20 |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
7059 |
0.13 |
chr1_21259850_21260251 | 0.20 |
Gsta3 |
glutathione S-transferase, alpha 3 |
6529 |
0.11 |
chr17_57219489_57219667 | 0.20 |
C3 |
complement component 3 |
394 |
0.74 |
chr3_10370926_10371217 | 0.20 |
Chmp4c |
charged multivesicular body protein 4C |
4113 |
0.15 |
chr9_55277952_55278103 | 0.20 |
Nrg4 |
neuregulin 4 |
5545 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.4 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.1 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.0 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.0 | 0.1 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.0 | 0.0 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0061010 | gall bladder development(GO:0061010) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.0 | 0.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.0 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.0 | 0.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.0 | 0.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.0 | 0.0 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.0 | 0.0 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 | 0.0 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.0 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.0 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.0 | 0.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.2 | GO:0043798 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.0 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0043338 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.0 | 0.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.5 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.4 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |